Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Francesca, Paradiso"'
Autor:
Ava A Brozovich, Stefania Lenna, Francesca Paradiso, Stefano Serpelloni, Patrick McCulloch, Bradley Weiner, Jason T Yustein, Francesca Taraballi
Publikováno v:
Journal of Tissue Engineering, Vol 13 (2022)
Osteosarcoma (OS) is the most common bone tumor in pediatrics. After resection, allografts or metal endoprostheses reconstruct bone voids, and systemic chemotherapy is used to prevent recurrence. This urges the development of novel treatment options
Externí odkaz:
https://doaj.org/article/403e66be91f64de6bfbca8431ecffcaf
Autor:
Jeffrey L. Van Eps, Joseph S. Fernandez-Moure, Fernando J. Cabrera, Francesca Taraballi, Francesca Paradiso, Silvia Minardi, Xin Wang, Bayan Aghdasi, Ennio Tasciotti, Bradley K. Weiner
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 9 (2021)
Remodeling of the human bony skeleton is constantly occurring with up to 10% annual bone volume turnover from osteoclastic and osteoblastic activity. A shift toward resorption can result in osteoporosis and pathologic fractures, while a shift toward
Externí odkaz:
https://doaj.org/article/f955d92ff46b45d08b5e01112f9c42e4
Autor:
Gabriele Romano, Francesca Paradiso, Peng Li, Pooja Shukla, Lindsay N. Barger, Olivia El Naggar, John P. Miller, Roger J. Liang, Timothy L. Helms, Alexander J. Lazar, Jennifer A. Wargo, Francesca Taraballi, James C. Costello, Lawrence N. Kwong
Publikováno v:
Cancer Immunology Research. 11:558-569
Patients with BRAF-mutant melanoma show significant responses to combined BRAF and MEK inhibition, but most relapse within 2 years. A major reservoir for drug resistance is minimal residual disease (MRD), comprised of drug-tolerant tumor cells laying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a40f2da886564af721e6bfcc62c6c6d4
https://doi.org/10.1158/2326-6066.cir-22-0224
https://doi.org/10.1158/2326-6066.cir-22-0224
Autor:
Chiara Fucci, Massimo Resnati, Elena Riva, Tommaso Perini, Elena Ruggieri, Ugo Orfanelli, Francesca Paradiso, Floriana Cremasco, Andrea Raimondi, Elena Pasqualetto, Mario Nuvolone, Luca Rampoldi, Simone Cenci, Enrico Milan
Publikováno v:
Cell Reports, Vol 32, Iss 12, Pp 108162- (2020)
Summary: FAM46C is a non-canonical poly(A) polymerase uniquely mutated in up to 20% of multiple myeloma (MM) patients, implying a tissue-specific tumor suppressor function. Here, we report that FAM46C selectively stabilizes mRNAs encoding endoplasmic
Externí odkaz:
https://doaj.org/article/ae1219dbb80b45f2be9d32a13af4f52b
Autor:
Francesca Paradiso, Stefania Lenna, S. Andrea Gazze, Jezabel Garcia Parra, Kate Murphy, Lavinia Margarit, Deyarina Gonzalez, Lewis Francis, Francesca Taraballi
Publikováno v:
Cells, Vol 11, Iss 5, p 824 (2022)
The mechanical homeostasis of tissues can be altered in response to trauma or disease, such as cancer, resulting in altered mechanotransduction pathways that have been shown to impact tumor development, progression, and the efficacy of therapeutic ap
Externí odkaz:
https://doaj.org/article/18938327565242ddad662c5bd723eaa1
Autor:
Stefania Lenna, Ava Brozovich, Takashi Hirase, Francesca Paradiso, Bradley K. Weiner, Francesca Taraballi
Publikováno v:
Stem Cells and Development. 31:672-683
Due to their immunosuppressive potential and ability to differentiate into multiple musculoskeletal cell lineages, mesenchymal stromal cells (MSCs) became popular in clinical trials for the treatment of musculoskeletal disorders. The aim of this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91044d8557927c980a4d18b3a0bb5807
https://doi.org/10.1089/scd.2022.0157
https://doi.org/10.1089/scd.2022.0157
Autor:
Francesca Paradiso, Joan Fitzgerald, Seydou Yao, Frank Barry, Francesca Taraballi, Deyarina Gonzalez, R. Steven Conlan, Lewis Francis
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 7 (2019)
A fundamental structural component of extracellular matrix in all connective and interstitial tissue, collagen is the most abundant protein in the human body. To date, mammalian collagens sources represent the golden standard for multiple biomedical
Externí odkaz:
https://doaj.org/article/0b72d97f5c0b4db59f8abe3d68aeaf03
Supplementary Tables from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma
Autor:
Lawrence N. Kwong, James C. Costello, Francesca Taraballi, Jennifer A. Wargo, Alexander J. Lazar, Timothy L. Helms, Roger J. Liang, John P. Miller, Olivia El Naggar, Lindsay N. Barger, Pooja Shukla, Peng Li, Francesca Paradiso, Gabriele Romano
Supplementary Tables S1-S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61a524dd6284dda5a6e2b38e7c181e49
https://doi.org/10.1158/2326-6066.22736965
https://doi.org/10.1158/2326-6066.22736965
Autor:
Lawrence N. Kwong, James C. Costello, Francesca Taraballi, Jennifer A. Wargo, Alexander J. Lazar, Timothy L. Helms, Roger J. Liang, John P. Miller, Olivia El Naggar, Lindsay N. Barger, Pooja Shukla, Peng Li, Francesca Paradiso, Gabriele Romano
Supplementary Figures S1-S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150d47f956ceb797ad53d571e97f7de3
https://doi.org/10.1158/2326-6066.22736971.v1
https://doi.org/10.1158/2326-6066.22736971.v1
Autor:
Lawrence N. Kwong, James C. Costello, Francesca Taraballi, Jennifer A. Wargo, Alexander J. Lazar, Timothy L. Helms, Roger J. Liang, John P. Miller, Olivia El Naggar, Lindsay N. Barger, Pooja Shukla, Peng Li, Francesca Paradiso, Gabriele Romano
Patients with BRAF-mutant melanoma show substantial responses to combined BRAF and MEK inhibition, but most relapse within 2 years. A major reservoir for drug resistance is minimal residual disease (MRD), comprised of drug-tolerant tumor cells laying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99adcc7a1ff884896453f038fd8e46c5
https://doi.org/10.1158/2326-6066.c.6627970
https://doi.org/10.1158/2326-6066.c.6627970